Neumann, Frank <br/><br/>
Determination of optimum vitamin D3 levels for NK cell-mediated rituximab- and obinutuzumab-dependent cellular cytotoxicity.  [electronic resource] 

 -  Cancer immunology, immunotherapy : CII  Nov 2018 
 - 1709-1718 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1432-0851 
<br/><br/><label>Standard No.: </label>10.1007/s00262-018-2224-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Humanized--pharmacology<br/>Antibody-Dependent Cell Cytotoxicity--immunology<br/>Antineoplastic Agents, Immunological--pharmacology<br/>Case-Control Studies<br/>Cholecalciferol--blood<br/>Cytotoxicity, Immunologic--immunology<br/>Female<br/>Healthy Volunteers<br/>Humans<br/>Killer Cells, Natural--immunology<br/>Lymphocyte Activation<br/>Lymphoma, Large B-Cell, Diffuse--blood<br/>Male<br/>Middle Aged<br/>Rituximab--pharmacology